Notifications
Back


AAVATAR Therapeutics is committed to advancing 

gene therapy through safe, eco-conscious, and sustainable operations.


As a leader in the global biopharmaceutical industry, 

we uphold the following principles in managing safety, 

environmental impact, and energy efficiency across all stages of R&D and manufacturing. 


Safety, Environmental, and Energy Management Policy


  1.  Occupational Health & Safety 
       We place the highest priority on the health and well-being of our employees and 
       establish a proactive safety management system with full workforce participation.
  • Conduct routine risk assessments and preventive safety audits to eliminate potential hazards.
  • Implement robust controls against biological and chemical exposure risks.
  • Foster a safety-first culture and build a resilient environment where all personnel are empowered to act safely.

  2.  Environmental Sustainability 
       We adopt environmentally responsible practices across our 
       biomanufacturing operations to reduce emissions and contribute to global sustainability.

  • Operate in accordance with ISO 14001-certified environmental management systems.

  • Minimize waste and pollutants through resource-efficient, low-impact production methods.

  • Integrate renewable materials and eco-friendly packaging into our supply chain.

  3.  Energy Efficiency & Low-Carbon Transition 
       We implement advanced energy-saving technologies and 
       pursue long-term carbon footprint reduction through optimized facility management.

  • Continuously reduce operational energy costs via high-efficiency infrastructure upgrades.

  • Adopt smart manufacturing and automation systems to enhance long-term energy efficiency.

  4.  Sustainable Growth through Internal Engagement 
       We strengthen our sustainability culture through employee engagement, education, and transparent governance. 

  • Provide regular training on SHE (Safety, Health, Environment) principles to all employees.

  • Continuously review and refine management systems for measurable, long-term improvement. 

  • Communicate sustainability goals with stakeholders and encourage alignment across the value chain.


Innovation in gene therapy, changing the lives of patients with rare and incurable diseases.


We are with you through the entire process of rare disease treatment, from the development of AAV platform technology to the production of customized treatments.



MON — FRI (8 AM ~ 5 PM)

TEL  |  070-4229-0321

EMAIL  |  information@aavatartps.com



COMPANY  |  AAVATAR Therapeutics

CEO  |  Seunghee Cho

BUSINESS NUMBER  |  235-81-02296


HQ

Unit 1023, Building B, 540 Misa-daero,

Hanam-si, Gyeonggi-do, Republic of Korea


BioHub

Room 203, R&D Center, Seoul Bio Hub, 117-3,

Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea


Copyright ⓒ 2025 AAVATAR Therapeutics All rights reserved.

Innovation in gene therapy, changing the lives of patients with rare and incurable diseases.



We are with you through the entire process of rare disease treatment, from the development of AAV platform technology to the production of customized treatments.

MON — FRI (8 AM ~ 5 PM)

TEL  |  070-4229-0321

EMAIL  |  information@aavatartps.com

COMPANY  |  AAVATAR Therapeutics    CEO  |  Seunghee Cho      BUSINESS NUMBER  |  235-81-02296

HQ  |  Unit 1023, Building B, 540 Misa-daero, Hanam-si, Gyeonggi-do, Republic of Korea

BioHub  |  Room 203, R&D Center, Seoul Bio Hub, 117-3, Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea


Copyright ⓒ 2025 AAVATAR Therapeutics All rights reserved. |  SITE BY. DOTCLE